Steven C Borkan

Title: Steven C. Borkan: Innovator in Kidney Injury Diagnosis and Treatment

Introduction

Steven C. Borkan is a notable inventor based in Medfield, MA (US). He has made significant contributions to the field of medical technology, particularly in the diagnosis and treatment of kidney injuries. With a total of 2 patents, his work focuses on innovative methods that can potentially improve patient outcomes in critical health situations.

Latest Patents

Borkan's latest patents include compositions and methods for diagnosing and/or treating kidney injury. One aspect of his technology involves methods, assays, and kits designed to identify ischemia and ischemic injury, including kidney injury. This technology is particularly useful in determining the efficacy of cancer treatments. Notably, differential phosphorylation of the nucleophosmin (NPM) polypeptide serves as an early marker of ischemic injuries such as acute kidney injury (AKI) and ischemic renal cell injury. Additionally, his patents cover compositions and methods for treating ischemia and kidney injury, which include NPM inhibitory agents, such as NPM inhibitory peptides.

Career Highlights

Steven C. Borkan is affiliated with Boston Medical Center Corporation, where he continues to advance his research and innovations. His work is instrumental in bridging the gap between laboratory research and clinical application, ensuring that his findings can be translated into real-world medical solutions.

Collaborations

Borkan collaborates with Zhiyong Wang, a fellow researcher, to further enhance the impact of their work in the medical field.

Conclusion

Steven C. Borkan's contributions to the diagnosis and treatment of kidney injuries highlight his role as an innovative inventor in the medical technology sector. His patents reflect a commitment to improving patient care through advanced scientific methods.